Brief: Surface Oncology Says Anticipates Will Have Net Cash Of $20 Million To $25 Million At The Closing Of The Proposed Mergers

Surface Oncology

31/08/2023 23:01

Aug 31 (Reuters) - Coherus BioSciences Inc  CHRS.O :
    * SURFACE ONCOLOGY INC- ANTICIPATES WILL HAVE NET CASH OF
$20
MILLION TO $25 MILLION AT THE CLOSING OF THE PROPOSED MERGERS
    * SURFACE ONCOLOGY INC- ANTICIPATES ITS REMAINING CASH AND
CASH
EQUIVALENTS WOULD PROVIDE RUNWAY THROUGH END OF 2023

Source text for Eikon:  ID: 
Further company coverage:  CHRS.O 

 ((Reuters.Brief@thomsonreuters.com;))